Similar articles

• Multiple sclerosis: pilot therapeutic trial of immunosuppressants.

  Cendrowski WS. Cendrowski WS. Schweiz Arch Neurol Neurochir Psychiatr. 1969;105(2):241-6. Schweiz Arch Neurol Neurochir Psychiatr. 1969. PMID: 4314087 No abstract available.
• Immunosuppressive drugs in multiple sclerosis: pro and con.

  Ellison GW, Myers LW. Ellison GW, et al. Neurology. 1980 Jul;30(7 Pt 2):28-32. doi: 10.1212/wnl.30.7_part_2.28. Neurology. 1980. PMID: 6248818 Review. No abstract available.
• [Cyclophosphamide in the therapy of multiple sclerosis].

  Salvatores U, Majeron M, Mascetti A. Salvatores U, et al. Riv Sper Freniatr Med Leg Alien Ment. 1972 Feb 29;96(1):163-84. Riv Sper Freniatr Med Leg Alien Ment. 1972. PMID: 4337775 Italian. No abstract available.
• [Critic study of multiple sclerosis treatment by chlorambucil and intraspinal corticotherapy. Apropos of 100 cases followed up from 2 to 9 years].

  Sigwald J, Mazalton A, Raymondeaud C, Piot C, Jacquillat C. Sigwald J, et al. Rev Neurol (Paris). 1973 Jan;128(1):72-7. Rev Neurol (Paris). 1973. PMID: 4367744 French. No abstract available.
• [Critical opinions on the treatment of multiple sclerosis with immunosuppressive agents].

  Skłodowski P. Skłodowski P. Neurol Neurochir Pol. 1993 Nov-Dec;27(6):877-83. Neurol Neurochir Pol. 1993. PMID: 8164783 Review. Polish.